These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21180163)

  • 21. Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons.
    Kjaer A; Larsen PJ; Knigge U; Møller M; Warberg J
    Endocrinology; 1994 Jan; 134(1):482-91. PubMed ID: 8275963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of catecholamine-depleting medullary knife cuts on corticotropin-releasing factor and vasopressin immunoreactivity in the hypothalamus of normal and steroid-manipulated rats.
    Sawchenko PE
    Neuroendocrinology; 1988 Nov; 48(5):459-70. PubMed ID: 2469027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen-sensitive changes in regulation of restraint-induced adrenocorticotropin secretion between early and late puberty in male rats.
    Gomez F; Manalo S; Dallman MF
    Endocrinology; 2004 Jan; 145(1):59-70. PubMed ID: 14563697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status.
    De Goeij DC; Dijkstra H; Tilders FJ
    Endocrinology; 1992 Aug; 131(2):847-53. PubMed ID: 1322285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenalectomy enhances endotoxemia-induced hypophagia: higher activation of corticotrophin-releasing-factor and proopiomelanocortin hypothalamic neurons.
    Rorato R; Castro M; Borges BC; Benedetti M; Germano CM; Antunes-Rodrigues J; Elias LL
    Horm Behav; 2008 Jun; 54(1):134-42. PubMed ID: 18374921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO; Plotsky PM; Vale WW
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami.
    Ackland JF; Ratter SJ; Bourne GL; Rees LH
    J Endocrinol; 1986 Feb; 108(2):171-80. PubMed ID: 3485168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in responsiveness of the hypothalamic-pituitary-adrenocortical axis to 2-deoxy-D-glucose in developing rats.
    Widmaier EP
    Endocrinology; 1990 Jun; 126(6):3116-23. PubMed ID: 2161749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of angiotensin II on release of CRH and AVP from hypothalamus during acute hypoxia.
    Wu Y; Du JZ
    Acta Pharmacol Sin; 2000 Nov; 21(11):1035-8. PubMed ID: 11501060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
    Antoni FA; Holmes MC; Kiss JZ
    Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine vasopressin and corticotropin releasing factor: binding to ovine anterior pituitary membranes.
    Shen PJ; Clarke IJ; Canny BJ; Funder JW; Smith AI
    Endocrinology; 1990 Nov; 127(5):2085-9. PubMed ID: 2226302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of fos-like immunoreactivity in hypothalamic corticotropin-releasing factor neurons after adrenalectomy in the rat.
    Jacobson L; Sharp FR; Dallman MF
    Endocrinology; 1990 Mar; 126(3):1709-19. PubMed ID: 2155109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats.
    Patchev VK; Kalogeras KT; Zelazowski P; Wilder RL; Chrousos GP
    Endocrinology; 1992 Sep; 131(3):1453-7. PubMed ID: 1505475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats.
    Whitnall MH; Smyth D; Gainer H
    Neuroendocrinology; 1987 May; 45(5):420-4. PubMed ID: 3295576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of peptide release from fetal rat hypothalamic neurones cultured in defined media and serum-containing media.
    Clarke MJ; Gillies GE
    J Endocrinol; 1988 Mar; 116(3):349-56. PubMed ID: 2895160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.